Leadership change at Brown-Forman comes as business pressures build

Brown-Forman (BF.B) has entered a leadership transition after CEO and President Lawson Whiting announced plans to retire, just as the company reports several years of sales declines and weaker operating efficiency.

At a share price of US$26.41, Brown-Forman has had a 7 day share price return of 5.34%, but its 1 year total shareholder return is down 11.62% and the 5 year total shareholder return is down 59.16%, which points to fading longer term momentum as the CEO retirement adds another layer of uncertainty.

If this leadership transition has you reviewing your watchlist, it could be a good moment to broaden your search and uncover 18 top founder-led companies

Bulls may view Brown-Forman’s long history and global spirits portfolio as a basis for patience, while bears focus on weaker shareholder returns and softer sales. Which side does the current valuation appear to favor?

Most Popular Narrative: 5.8% Undervalued

At a last close of $26.41 against a narrative fair value of $28.03, Brown-Forman is framed as modestly undervalued, with that gap tied directly to specific earnings and margin assumptions.

Analysts are assuming Brown-Forman's revenue will grow by 1.7% annually over the next 3 years. Analysts assume that profit margins will increase from 18.2% today to 19.6% in 3 years time.

Curious what kind of sales mix and margin profile needs to hold for that valuation to stack up? The most followed narrative leans on measured revenue growth, firmer profitability and a tighter share count to bridge today’s price with that fair value, but the exact mix of those ingredients may surprise you.

Result: Fair Value of $28.03 (UNDERVALUED)

However, this picture for Brown-Forman still depends on a broad demand recovery in key spirits markets, as well as on cost pressures not eroding the margin story.

Next Steps

With both caution and optimism running through the Brown-Forman story, now is a good time to review the numbers yourself and stress test your thesis against the 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Brown-Forman?

If Brown-Forman has you reassessing your portfolio, do not stop here. Broadening your opportunity set now could help you identify additional candidates for further research.

• Explore companies that pair healthy finances and earnings strength using the solid balance sheet and fundamentals stocks screener (49 results).
• Review potential mispricings by scanning the market with the 47 high quality undervalued stocks.
• Find off-the-radar opportunities with the screener containing 20 high quality undiscovered gems for ideas that may warrant a closer look.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.